- Home
- CLLS vs SBT Comparison
CLLS vs SBT Comparison
Compare CLLS & SBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- SBT
- Stock Information
- Founded
- CLLS 1999
- SBT 1984
- Country
- CLLS France
- SBT United States
- Employees
- CLLS N/A
- SBT N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- SBT Savings Institutions
- Sector
- CLLS Health Care
- SBT Finance
- Exchange
- CLLS Nasdaq
- SBT Nasdaq
- Market Cap
- CLLS 240.2M
- SBT 253.2M
- IPO Year
- CLLS 2007
- SBT 2017
- Fundamental
- Price
- CLLS $1.57
- SBT $4.77
- Analyst Decision
- CLLS Buy
- SBT
- Analyst Count
- CLLS 3
- SBT 0
- Target Price
- CLLS $7.00
- SBT N/A
- AVG Volume (30 Days)
- CLLS 56.7K
- SBT 27.7K
- Earning Date
- CLLS 11-04-2024
- SBT 01-22-2025
- Dividend Yield
- CLLS N/A
- SBT N/A
- EPS Growth
- CLLS N/A
- SBT N/A
- EPS
- CLLS N/A
- SBT 0.12
- Revenue
- CLLS $36,042,000.00
- SBT $67,988,000.00
- Revenue This Year
- CLLS $271.02
- SBT N/A
- Revenue Next Year
- CLLS $33.48
- SBT $6.68
- P/E Ratio
- CLLS N/A
- SBT $39.94
- Revenue Growth
- CLLS 46.96
- SBT N/A
- 52 Week Low
- CLLS $1.53
- SBT $4.40
- 52 Week High
- CLLS $3.55
- SBT $5.97
- Technical
- Relative Strength Index (RSI)
- CLLS 27.91
- SBT 45.25
- Support Level
- CLLS $1.85
- SBT $4.71
- Resistance Level
- CLLS $2.09
- SBT $4.87
- Average True Range (ATR)
- CLLS 0.09
- SBT 0.04
- MACD
- CLLS -0.04
- SBT -0.01
- Stochastic Oscillator
- CLLS 0.00
- SBT 37.50
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About SBT Sterling Bancorp Inc.
Sterling Bancorp Inc is a unitary thrift holding company. Its primary business is the operation of its wholly-owned subsidiary, Sterling Bank, through which it offers a range of loan products to the residential and commercial markets, as well as retail banking services. The products and services offered by the bank include saving and current accounts, demand and term deposits, payment cards, trade finance, fund transfer, treasury and cash management. It provides services such as construction loans, residential real estate, commercial real estate, commercial lines of credit and other consumer loans.